Project Team 1: Use of patient registry data in the development of ‘real world’ economic information on health care costs (Real World HC Costs).
Chair: Lynn Okamoto PhD
Members: Jacqui Miot PhD; Sue Gao PhD, MPH; Scott McKenzie MD; Krista Payne MEd;
Susan Shiff PhD; Alicia Shillington PhD, MPH
- Sources of economic and financial data to be included in patient registries.
- Health care resource utilization.
- Recommendations for how health care decision makers can use economic data from registries.
Project Team 2: Use of patient registry data in evaluating patient-reported outcomes (PRO EVAL).
Chair: Carl Asche PhD
Members: Tao Fan PhD, MS; Mark Jewell PhD; Michael Pollock; Matthew Reaney MSc;
Wendy Toler PharmD; Kathi Weis PhD, DrPH
- Identify ways to incorporate PROs into registries to build evidence for health care decision-making.
- Recommendations for how health care decision makers can use PRO data collected in registries.
Project Team 3: Use of patient registry data as a complement to randomized clinical trial data (PR & RCT DATA).
Chair: Steve Takemoto PhD
Members: Nancy Dreyer PhD, MPH; Claudio Faria PharmD, MPH; Trisha Hutzul MSPH;
Gerlinde Kaempf MA; Pat McCollam RPh, BS, PharmD; Fang Wang PhD, MD;
Jaroslaw Wechowski PhD, MD; Jasmanda Wu PhD, MPH
- Hierarchy of evidence.
- Internal validity versus external validity.
- Randomized clinical trial strengths and weaknesses.
- Patient registry strengths and weaknesses.
- Good research practices for the use of patient registry data as a complement to randomized clinical trial evidence.
Project 4: An annotated patient registry bibliography (in development)
- Background articles on patient registries
- Peer-reviewed journal articles on registries and use of registry data
Project 5: Development of a Patient Registry Directory (in development)
- Review clinical trial directories
- Research & compile entries for directory
|